Guggenheim Securities is issuing a statement on behalf of former Pfizer CEO Ian Read and former Pfizer CFO Frank D’Amelio: “We have decided not to be involved in the efforts of Starboard Value regarding Pfizer. We are fully supportive of Pfizer Chairman & CEO Albert Bourla, senior management and the board, and we are confident that over time they will deliver shareholder value.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- DOJ may push for breakup of Google: Morning Buzz
- Pfizer call volume above normal and directionally bullish
- On drug prices, Harris pushes for cuts, Trump offers few specifics, NYTimes say
- Pfizer (NYSE:PFE) CEO to Meet Activist Investor Starboard Value
- Pfizer CEO Bourla to meet with Starboard, FT reports